Results

Total Results: 73 records

Showing results for "kind".

41. Screening for Intimate Partner Violence and Abuse of Elderly and Vulnerable Adults: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/aSTzfuKHZtT8_PjfJjuck5
    March 01, 2013 - rape or during their most recent physical assault (30.2%) actually received medical treatment of any kind

42. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: A Reaffirmation Evidence Update for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16935/GON-final-evidence-review/pdf
    January 01, 2019 - Ophthalmia neonatorum: what kind of prophylaxis? J Matern Fetal Neonatal Med. 2011;24(6):769-73.

43. Screening for Colorectal Cancer: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/n4sdjxShTApRE6UxvyYuzG
    November 01, 2008 - Screening for Colorectal Cancer: Recommendation Statement Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force* Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colo- rec…

44. Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening
    February 15, 2013 - We also failed to find evidence linking treatment of any kind to patient-reported outcomes or visual

45. Archived: Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening-2013
    February 15, 2013 - We also failed to find evidence linking treatment of any kind to patient-reported outcomes or visual

46. Recommendation: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults
    June 20, 2023 - The broadest analysis (any type of psychotherapy compared with any kind of control condition, measuring

47. Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF_Y9vcT3eNPdHjTxPZsUZ
    April 17, 2023 - The broadest analysis (any type of psychotherapy compared with any kind of control condition, measuring

48. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
    May 06, 2002 - archived Evidence Summary Breast Cancer: Medications for Risk Reduction May 06, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and …

49. Chemo and Couns/2nd instal (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
    July 01, 2002 - Chemo and Couns/2nd instal 33 Epidemiology Despite improvements in the rates of screening and early detection, treatment advances, and healthier lifestyles, breast cancer remains the most common non-skin cancer among women in the United States. In 2002, it will account for an estimated 203,500 new cases of invasiv…

50. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Breast Cancer: Medications for Risk Reduction May 06, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They shoul…

51. Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/mTPBWPMDqfuWvodfd5R5Ms
    November 01, 2012 - Rudin C, Spaenhauer A, Keiser O, Rickenbach M, Kind C, Aebi-Popp K, et al; Swiss HIV Cohort Study (SHCS

52. Archived: Screening for HIV in Pregnant Women: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-pregnant-women-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
    November 15, 2012 - [PMID: 17457096] Rudin C, Spaenhauer A, Keiser O, Rickenbach M, Kind C, Aebi-Popp K, et al; Swiss HIV

53. High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-10/2023-annual-report-to-congress.pdf
    January 01, 2023 - High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress November 2021 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Michael J. Barry, Chair Dr. Wanda K. Nicholson, Vice Chair Dr. Michael Silverstein, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE…

54. High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/2023-annual-report-to-congress.pdf
    January 01, 2023 - High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress November 2021 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Michael J. Barry, Chair Dr. Wanda K. Nicholson, Vice Chair Dr. Michael Silverstein, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE…

55. Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
    January 10, 2017 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print Evidence Summary Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication January 10, 2017 Recommendations made by the USP…

56. Archived: Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication January 10, 2017 Recommendations made by the USPSTF are independent of t…

57. Archived: Final Evidence Review: Gonorrhea: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review40/gonorrhea-screening
    May 15, 2005 - Of those testing positive for gonorrhea, 40 percent reported having symptoms of any kind. … Of those testing positive for gonorrhea, 40% reported having symptoms of any kind, and 60% were co-infected

58. Archived: Final Evidence Review: Gonorrhea: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review40/gonorrhea-screening-2005
    May 15, 2005 - Of those testing positive for gonorrhea, 40 percent reported having symptoms of any kind. … Of those testing positive for gonorrhea, 40% reported having symptoms of any kind, and 60% were co-infected

59. Evidence Summary: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
    July 26, 2022 - Thirteen trials reported adverse events or serious adverse events of any kind, 29-31 , 33 , 41 , 48 ,

60. Screening for Gonorrhea: Update of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wezro6zTSfAWxCrneF-nxB
    May 01, 2005 - Of those testing positive for gonorrhea, 40% reported having symptoms of any kind. … Of those testing posi gonorrhea, 40% reported having symptoms of any kind, and 60% were co-infected with